Non-Current Assets
Total Assets
United Therapeutics Total Assets decreased by 14.8% to $6.71B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 13.3%, from $7.74B to $6.71B. Over 5 years (FY 2020 to FY 2025), Total Assets shows an upward trend with a 11.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryMarket Position
SignalHigher is better
VolatilityStable
First reportedQ4 2015
Last reportedQ1 2026
How to read this metric
Growth generally indicates business expansion, while a decline may suggest asset liquidation or a contraction in business scale.
Detailed definition
This is the sum of all current and non-current assets owned by the company, representing the total resource base availab...
Peer comparison
Universal financial metric used by all public companies to define the size of the balance sheet.
Metric ID:
total_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.84B | $5.05B | $5.17B | $5.36B | $5.54B | $5.78B | $6.04B | $6.35B | $6.68B | $7.02B | $7.17B | $6.50B | $6.72B | $7.12B | $7.36B | $7.74B | $7.91B | $7.35B | $7.88B | $6.71B |
| QoQ Change | — | +4.2% | +2.4% | +3.7% | +3.4% | +4.3% | +4.5% | +5.0% | +5.3% | +5.1% | +2.0% | -9.4% | +3.5% | +5.9% | +3.4% | +5.2% | +2.1% | -7.0% | +7.2% | -14.8% |
| YoY Change | — | — | — | — | +14.4% | +14.5% | +16.9% | +18.4% | +20.5% | +21.5% | +18.6% | +2.4% | +0.6% | +1.4% | +2.7% | +19.2% | +17.6% | +3.2% | +7.0% | -13.3% |
Range$4.84B – $7.91B
CAGR+7.1%
Avg YoY Growth+10.4%
Median YoY Growth+14.5%
Total Assets at Other Companies
Frequently Asked Questions
- What is United Therapeutics's total assets?
- United Therapeutics (UTHR) reported total assets of $6.71B in Q1 2026.
- How has United Therapeutics's total assets changed year-over-year?
- United Therapeutics's total assets decreased by 13.3% year-over-year, from $7.74B to $6.71B.
- What is the long-term trend for United Therapeutics's total assets?
- Over 5 years (2020 to 2025), United Therapeutics's total assets has grown at a 11.3% compound annual growth rate (CAGR), from $4.62B to $7.88B.
- What does total assets mean?
- The total value of everything the company owns.